Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ILRUN pseudogene 1 (ILRUNP1) is a **pseudogene**—a non-coding genomic sequence with high homology to the functional ILRUN gene but lacking protein-coding capacity[4]. Pseudogenes do not typically produce functional proteins and are not considered molecular drug targets. By contrast, the related ILRUN protein-coding gene (previously known as C6orf106) encodes a conserved protein involved in negative regulation of type I interferon and TNF-α transcription, immune response, and lipid metabolism, and is linked to several disease processes including obesity, cardiovascular disease, infection, and cancer[1][2][3][5]. However, the pseudogene ILRUNP1 itself does not have evidence of therapeutic or molecular target relevance. If you are seeking information about a druggable target or biomarker, focus on **ILRUN (Inflammation and lipid regulator with UBA-like and NBR1-like domains, also C6orf106)**, not ILRUNP1.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ILRUN pseudogene 1 (ILRUNP1).